NYSE:CNVY • US21258C1080
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Convey Health Solutions Holdings Inc (CNVY).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-06-22 | Guggenheim | Downgrade | Buy -> Neutral |
| 2022-06-22 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2022-05-12 | Goldman Sachs | Maintains | Neutral |
| 2021-07-12 | Barclays | Initiate | Overweight |
| 2021-07-12 | Truist Securities | Initiate | Buy |
| 2021-07-12 | JP Morgan | Initiate | Neutral |
| 2021-07-12 | Canaccord Genuity | Initiate | Buy |
| 2021-07-12 | B of A Securities | Initiate | Buy |
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 221.153M | 282.914M 27.93% | 337.596M 19.33% | 409.794M 21.39% | 475.775M 16.10% | 546.829M 14.93% | 619.297M 13.25% | 715.397M 15.52% | |
| EBITDA YoY % growth | 15.117M | 52.606M 247.99% | 51.913M -1.32% | 80.04M 54.18% | 95.991M 19.93% | 113.106M 17.83% | 131.823M 16.55% | 156.709M 18.88% | |
| EBIT YoY % growth | -7.43M | 24.574M 430.74% | 21.433M -12.78% | 36.414M 69.90% | 56.818M 56.03% | 74.601M 31.30% | 105.074M 40.85% | 150.955M 43.67% | |
| Operating Margin | -3.36% | 8.69% | 6.35% | 8.89% | 11.94% | 13.64% | 16.97% | 21.10% | |
| EPS YoY % growth | N/A | N/A | N/A | 0.25 406.25% | 0.44 75.00% | 0.70 60.93% | 1.16 64.67% | 1.95 67.97% |
All data in USD
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.09 83.60% | 0.15 1,430.00% | 0.04 278.50% | 0.07 147.36% | 0.11 16.67% | 0.21 36.67% |
| Revenue Q2Q % growth | 100.068M 21.43% | 119.498M 22.81% | 106.82M 10.46% | 104.321M 16.19% | 116.28M 16.20% | 146.37M 22.49% |
| EBITDA Q2Q % growth | 22.175M -30.36% | 29.065M -29.39% | 14.994M 35.63% | 21.42M 46.37% | 24.582M 10.86% | 37.944M 30.55% |
| EBIT Q2Q % growth | 10.803M 17.75% | 17.779M 66.45% | 7.508M 167.86% | 8.924M 439.19% | 14.076M 30.30% | 27.336M 53.76% |
All data in USD
9 analysts have analysed CNVY and the average price target is 11.22 USD. This implies a price increase of 6.76% is expected in the next year compared to the current price of 10.51.
Convey Health Solutions Holdings Inc (CNVY) will report earnings on 2022-11-09, after the market close.
The consensus EPS estimate for the next earnings of Convey Health Solutions Holdings Inc (CNVY) is 0.09 USD and the consensus revenue estimate is 100.07M USD.
The number of analysts covering Convey Health Solutions Holdings Inc (CNVY) is 9.